ES2301697T3 - Matrices de proteina modificada con factor de crecimiento para ingenieria de tejidos. - Google Patents

Matrices de proteina modificada con factor de crecimiento para ingenieria de tejidos. Download PDF

Info

Publication number
ES2301697T3
ES2301697T3 ES02792510T ES02792510T ES2301697T3 ES 2301697 T3 ES2301697 T3 ES 2301697T3 ES 02792510 T ES02792510 T ES 02792510T ES 02792510 T ES02792510 T ES 02792510T ES 2301697 T3 ES2301697 T3 ES 2301697T3
Authority
ES
Spain
Prior art keywords
matrix
baselineskip
pth
domain
fusion peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES02792510T
Other languages
English (en)
Spanish (es)
Inventor
Jeffrey A. Hubbell
Matthias Lutolf
Jason Schense
Anna Jen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eidgenoessische Technische Hochschule Zurich ETHZ
Universitaet Zuerich
Original Assignee
Eidgenoessische Technische Hochschule Zurich ETHZ
Universitaet Zuerich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/024,918 external-priority patent/US20020168718A1/en
Priority claimed from PCT/EP2002/012458 external-priority patent/WO2003040235A1/en
Priority claimed from US10/323,046 external-priority patent/US7601685B2/en
Application filed by Eidgenoessische Technische Hochschule Zurich ETHZ, Universitaet Zuerich filed Critical Eidgenoessische Technische Hochschule Zurich ETHZ
Application granted granted Critical
Publication of ES2301697T3 publication Critical patent/ES2301697T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/225Fibrin; Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/635Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Transplantation (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES02792510T 2001-12-18 2002-12-18 Matrices de proteina modificada con factor de crecimiento para ingenieria de tejidos. Expired - Lifetime ES2301697T3 (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US24918 2001-12-18
US10/024,918 US20020168718A1 (en) 1997-04-03 2001-12-18 Enzyme-mediated modification of fibrin for tissue engineering
WOPCT/EP02/12458 2002-11-07
PCT/EP2002/012458 WO2003040235A1 (en) 2001-11-07 2002-11-07 Synthetic matrix for controlled cell ingrowth and tissue regeneration
US323046 2002-12-17
US10/323,046 US7601685B2 (en) 1998-08-27 2002-12-17 Growth factor modified protein matrices for tissue engineering

Publications (1)

Publication Number Publication Date
ES2301697T3 true ES2301697T3 (es) 2008-07-01

Family

ID=27807134

Family Applications (1)

Application Number Title Priority Date Filing Date
ES02792510T Expired - Lifetime ES2301697T3 (es) 2001-12-18 2002-12-18 Matrices de proteina modificada con factor de crecimiento para ingenieria de tejidos.

Country Status (9)

Country Link
JP (2) JP4560291B2 (de)
AT (1) ATE386545T1 (de)
AU (2) AU2002358272B2 (de)
BR (1) BRPI0215192B8 (de)
CA (1) CA2470419A1 (de)
DE (1) DE60225185T2 (de)
ES (1) ES2301697T3 (de)
MX (1) MXPA04006021A (de)
WO (1) WO2003052091A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7351423B2 (en) 2004-09-01 2008-04-01 Depuy Spine, Inc. Musculo-skeletal implant having a bioactive gradient
SE0403014D0 (sv) 2004-12-10 2004-12-10 Straumann Holding Ag New protein formulation
EP1862170B1 (de) 2004-12-10 2012-03-14 Straumann Holding AG Emailleformulierung mit Amelogenin
JP5069125B2 (ja) * 2004-12-10 2012-11-07 シュトラウマン・ホールディング・アクチェンゲゼルシャフト 新規なタンパク質配合物
AU2005318097A1 (en) * 2004-12-22 2006-06-29 Kuros Biosurgery Ag Michael-type addition reaction functionalised peg hydrogels with factor XIIIA incorporated biofactors
CA2592973A1 (en) * 2005-01-06 2006-07-13 Kuros Biosurgery Ag Supplemented matrices for the repair of bone fractures
US8575101B2 (en) 2005-01-06 2013-11-05 Kuros Biosurgery Ag Supplemented matrices for the repair of bone fractures
WO2006073711A2 (en) * 2005-01-06 2006-07-13 Kuros Biosurgery Ag Use of a matrix comprising a contrast agent in soft tissues
EP3091075B1 (de) 2007-04-09 2018-06-13 The Board of Trustees of The University of Arkansas Fusionsproteine von kollagenbindender domäne und parathyroidhormon
ATE543520T1 (de) 2007-04-13 2012-02-15 Kuros Biosurgery Ag Polymergewebeversiegelung
EP2203195A2 (de) * 2007-10-12 2010-07-07 Kuros Biosurgery AG Injizierbare fibrinzusammensetzungen für gewebevermehrung mit strontiumsalz
EP2279021B1 (de) 2008-04-18 2013-02-13 Kuros Biosurgery AG Ausgabevorrichtung, kit mit dieser vorrichtung und verfahren zum betrieb der vorrichtung
WO2011025957A2 (en) * 2009-08-28 2011-03-03 Ecole Polytechnique Federal De Lausanne Tg-aprotinin fusion proteins and matrices thereof
JP6120778B2 (ja) * 2011-02-03 2017-04-26 ノースイースタン ユニヴァーシティ 生物学的材料の極めて特異的な捕獲および遊離のための方法および組成物
EP2686027B1 (de) 2011-03-16 2021-05-05 Kuros Biosurgery AG Pharmazeutische formulierung zur verwendung für die wirbelsäulenfusion
ES2816009T3 (es) 2011-12-14 2021-03-31 Univ Arkansas Administración de agentes terapéuticos mediante una proteína de unión a colágeno
US9526765B2 (en) 2012-02-09 2016-12-27 The Kitasato Institute Delivery of therapeutic agents by a collagen binding protein
CN104619727B (zh) * 2012-06-25 2019-04-05 布里格姆及妇女医院股份有限公司 靶向治疗
US9790264B2 (en) 2012-06-25 2017-10-17 The Brigham And Women's Hospital, Inc. Compounds and methods for modulating pharmacokinetics
CA2992692C (en) * 2015-09-09 2021-12-21 Eth Zurich Injectable macroporous hydrogels
WO2018148573A1 (en) 2017-02-10 2018-08-16 The Board Of Trustees Of The University Of Arkansas Collagen-binding agent compositions and methods of using the same
EP3536353A1 (de) 2018-03-09 2019-09-11 Kuros Biosurgery AG Verfahren und kits zur herstellung einer fibrinmatrix

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171670A (en) * 1989-05-12 1992-12-15 The General Hospital Corporation Recombinant dna method for production of parathyroid hormone
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
JP2000500019A (ja) * 1995-11-16 2000-01-11 ロシュ ダイアグノスティクス ゲゼルシャフト ミット ベシュレンクテル ハフツング ストレプトアビジン融合タンパク質経由でのペプチドの生産方法
CN1281467A (zh) * 1997-12-18 2001-01-24 伊莱利利公司 结晶特立帕肽
ATE514729T1 (de) * 1999-02-01 2011-07-15 Eidgenoess Tech Hochschule Biomaterialien die durch nukleophile reaktion auf konjugierten ungesättigten gruppen addiert sind
JP2001190280A (ja) * 1999-02-19 2001-07-17 Terumo Corp コラーゲン結合性生理活性ポリペプチド

Also Published As

Publication number Publication date
MXPA04006021A (es) 2005-08-19
JP2009102383A (ja) 2009-05-14
JP4560291B2 (ja) 2010-10-13
CA2470419A1 (en) 2003-06-26
BR0215192A (pt) 2005-04-26
WO2003052091A1 (en) 2003-06-26
ATE386545T1 (de) 2008-03-15
AU2009201588B2 (en) 2011-02-24
DE60225185T2 (de) 2009-02-19
AU2009201588A1 (en) 2009-05-14
BRPI0215192B1 (pt) 2016-03-22
WO2003052091A8 (en) 2003-08-07
AU2002358272B2 (en) 2009-01-22
BRPI0215192B8 (pt) 2021-07-27
AU2002358272A1 (en) 2003-06-30
JP2005517658A (ja) 2005-06-16
DE60225185D1 (de) 2008-04-03

Similar Documents

Publication Publication Date Title
ES2301697T3 (es) Matrices de proteina modificada con factor de crecimiento para ingenieria de tejidos.
US8034618B2 (en) PTH containing cell growth matrix
ES2476996T3 (es) Tratamiento local de defectos óseos con matriz de liberación de PTH
ES2902872T3 (es) Matrices suplementadas para la reparación de fracturas óseas
ES2368988T3 (es) Bio-materiales formados por reacción de adición nucleófila a grupos insaturados conjugados.
EP1406678B1 (de) Arzneimittel freisetzende matrizen zur förderung der wundheilung
ES2451651T3 (es) Composiciones de liberación inmediata para el tratamiento de daños tisulares
KR101054023B1 (ko) 세포 내증식 및 조직 재생을 제어하기 위한 합성 매트릭스
ES2386258T3 (es) Relaciones de adición conjugadas para la entrega controlada de compuestos farmacéuticamente activos
EP1465989B1 (de) Wachstumsfaktor-modifizierte proteinmatrizes zur geweberekonstruktion (tissue engineering)
KR100925070B1 (ko) 성장인자로 변형된 조직 엔지니어링용 단백질 메트릭스
EP1864681A1 (de) Wachstumsfaktormodifizierte Proteinmatrizes zur Geweberekonstruktion
EP1837040A2 (de) Arzneimittel freisetzende Matrizen zur Förderung der Wundheilung
CN101098717A (zh) 用于修复骨折的补充的基质